International Conference on Radiopharmaceutical Sciences

International Conference on Radiopharmaceutical Sciences
Name	International Conference on Radiopharmaceutical Sciences
Abbreviation	ICRS
Discipline	Radiopharmaceutical chemistry
Frequency	Biennial
Established	1987
Venue	Varies

International Conference on Radiopharmaceutical Sciences is a biennial meeting that convenes researchers, clinicians, and industry representatives in radiopharmacy, nuclear medicine, and molecular imaging. The conference functions as a focal point for exchange among participants from institutions such as Brookhaven National Laboratory, Lawrence Berkeley National Laboratory, Massachusetts General Hospital, Johns Hopkins Hospital, and Mayo Clinic. Delegates commonly represent organizations including International Atomic Energy Agency, World Health Organization, European Association of Nuclear Medicine, Society of Nuclear Medicine and Molecular Imaging, and American Chemical Society.

History

The conference was initiated in the late 20th century with roots tracing to symposia held at Oak Ridge National Laboratory and workshops organized by International Union of Pure and Applied Chemistry committees and the European Commission. Early organizers included scientists affiliated with University of Oxford, University of Cambridge, Karolinska Institutet, University of Tokyo, University of Paris, Max Planck Society, and ETH Zurich. Over successive editions, venues rotated through cities such as Vienna, Boston, Tokyo, Stockholm, Paris, Berlin, Rome, Barcelona, Sydney, and Toronto. Plenary speakers have included investigators from Harvard University, Stanford University, University of California, Berkeley, Columbia University, and Imperial College London.

Organization and Governance

Governance typically involves steering committees drawn from national and international bodies such as International Atomic Energy Agency, European Commission, World Health Organization, European Association of Nuclear Medicine, Society of Nuclear Medicine and Molecular Imaging, and academic partners including University College London, King's College London, McGill University, University of Toronto, and University of Melbourne. Program committees include representatives from translational centers like Dana-Farber Cancer Institute, Institut Curie, Gustave Roussy, Karolinska University Hospital, and Sahlgrenska University Hospital. Financial and logistical support has been provided by funders including National Institutes of Health, European Research Council, Wellcome Trust, Canadian Institutes of Health Research, and corporate partners such as Siemens Healthineers, GE Healthcare, Philips Healthcare, Bracco Imaging, and Bayer AG. Oversight mechanisms reference ethical frameworks from Declaration of Helsinki signatories and regulatory guidance by agencies like U.S. Food and Drug Administration, European Medicines Agency, Health Canada, and Pharmaceuticals and Medical Devices Agency.

Conference Themes and Topics

Sessions cover radiotracer development, radiochemistry, and clinical translation with contributions from laboratories at MIT, Caltech, National Institutes of Health, Scripps Research, Riken, and Helmholtz Association. Recurring topics include positron emission tomography techniques influenced by work at CERN and cyclotron technology from TRIUMF, radiometal chemistry referencing methods developed at Argonne National Laboratory and Brookhaven National Laboratory, and antibody labeling strategies pioneered at Memorial Sloan Kettering Cancer Center and Fred Hutchinson Cancer Center. Other themes involve theranostics linked to research at University of Heidelberg, dosimetry approaches from International Commission on Radiological Protection, tracer kinetic modeling with contributions from Karolinska Institutet and University of Glasgow, and regulatory science informed by U.S. Food and Drug Administration workshops and European Medicines Agency white papers.

Notable Meetings and Proceedings

Notable editions have produced proceedings and special issues in journals such as The Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, Nuclear Medicine and Biology, Radiochemistry, and Molecular Imaging and Biology. Landmark meetings hosted in cities like Vienna and Boston featured landmark presentations on novel PET tracers from groups at Johns Hopkins University, Yale University, University of California, San Francisco, and Peking University. Sessions have highlighted multicenter trials coordinated with consortia including European Organization for Research and Treatment of Cancer and initiatives supported by Horizon 2020. Workshops on radiopharmaceutical manufacturing referenced standards from Good Manufacturing Practice guidance and case studies from Novartis and Roche development programs.

Awards and Recognitions

The conference has recognized scientific excellence through awards modeled on prizes such as the Nobel Prize-level acclaim within fields, and honours named after pioneers at institutions like Brookhaven National Laboratory, Lawrence Berkeley National Laboratory, Karolinska Institutet, University of Cambridge, and Imperial College London. Recipients often include investigators affiliated with Duke University, University of Michigan, University of Pennsylvania, Princeton University, University of Chicago, Weizmann Institute of Science, and Technion – Israel Institute of Technology. Awards emphasize innovation in radiochemistry, clinical translation, and regulatory impact, echoing distinctions similar to those conferred by Royal Society and National Academy of Sciences memberships.

Impact on Radiopharmaceutical Research and Industry

The conference has catalyzed collaborations between academic centers such as University of Oxford, University of Edinburgh, Kings College London, Seoul National University, and Tsinghua University and industry partners including GE Healthcare, Siemens Healthineers, Philips Healthcare, Bracco Imaging, Novartis, Roche, Bayer AG, and Lantheus Medical Imaging. Outcomes include accelerated tracer pipelines, standardized manufacturing protocols informed by International Organization for Standardization technical committees, and policy dialogues involving World Health Organization and International Atomic Energy Agency delegations. The meeting has also influenced training programs at universities like McMaster University and University of Sydney and contributed to clinical guidelines issued by professional societies such as European Association of Nuclear Medicine and Society of Nuclear Medicine and Molecular Imaging.

Category:Radiopharmacy conferences